Feature
ESMO21: Latest Clinical Studies Answer Central Questions in the Treatment of Leading Cancers
2021-09-22
Research Endeavors in Space Biology – Are We Gearing Towards Another Biological Moonshot?
2021-09-21
Novartis Expands Optogenetics Portfolio By Acquiring Swiss Startup for an Undisclosed Amount
2021-09-21
Day 2 ESMO 2021 Roundup: New Paradigms for Long-Term Cancer Care and Immunotherapies for High Risk Metastatic Cancers
2021-09-19
Day 1 ESMO 2021 Roundup: Investigational Immunotherapies Show Promise in Early Cancer Trials
2021-09-18